STABLE Score (TEVAR Risk) Calculator
Risk factor assessment
Select each finding present at presentation. Each selected factor contributes one point to the unweighted total.
The score total is a mathematical calculation only. The risk categories and 30-day mortality percentages in the original code have not been independently verified against an identifiable primary publication.
About this assessment
The supplied template describes a four-factor assessment intended to estimate 30-day mortality after thoracic endovascular aortic repair (TEVAR) for complicated type B aortic dissection. The implementation adds one point for each selected factor, producing a possible total of 0–4.
Important evidence limitation: the supplied citation, “Pape LA, et al. The STABLE Score: A Risk Model for 30-Day Mortality After TEVAR in Acute Type B Aortic Dissection,” with DOI 10.1016/j.jtcvs.2018.09.054, could not be verified as a matching publication in the search performed for this revision. The label “STABLE Score” may be confused with the STABLE endovascular device studies, which are not themselves evidence that this four-variable prediction score is validated.
Factors entered
| Factor | Scoring in this tool |
|---|---|
| Shock on presentation | 1 if present; otherwise 0 |
| Malperfusion | 1 if present; otherwise 0 |
| Age >70 years | 1 if present; otherwise 0 |
| Previous aortic surgery | 1 if present; otherwise 0 |
Interpretation and limitations
No low-, intermediate-, or high-risk mortality strata are shown because the percentages in the original code could not be substantiated from the cited source. Before describing this as a validated prediction model, confirm the original publication, exact predictor definitions, derivation population, calibration, discrimination, and external validation.
References and evidence notes
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.